Blog

The Canadian PBC Society is committed to advocating for people living with PBC. In the spring of 2026, 324 people living with PBC from across

Learn more about how AMA/ANA is used for PBC diagnosis and risk stratification.  This article was published in the November 2022 issue of Clinics in

In the present large, international retrospective cohort study, liver stiffness assessed by vibration-controlled transient elastography was validated as one of the strongest predictive factors of

“Little is known about PBC affecting subjects with heterogeneous genetic backgrounds [4]. Brazil has a population of a highly admixed origin, with varying proportions of

Study concludes that triple therapy with UDCA, OCA and fibrates is able to normalise biochemical liver tests and improve pruritus in patients with difficult‐to‐treat PBC. 

Since OCA (Ocaliva) was approved in the US in 2016 and Canada in 2017, there have been several  studies to assess its effectiveness in PBC

The Canadian Network for Autoimmune Liver disease (CaNAL) is a longitudinal observational cohort study of patients diagnosed with Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH),

Jacqueline A. G. M. Langedijk, Ulrich H. Beuers and Ronald P. J. Oude Elferink* published March 9, 2021, frontiers in Medicine. “Cholestasis is the term